News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
UBS Oncology Impact Fund L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/09/2023 |
SC 13G/A
| UBS Oncology Impact Fund L.P. reports a 0% stake in MEI Pharma, Inc. |
| 01/06/2022 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 158,579 shares
@ $42.05, valued at
$6.7M
Sold 32,396 shares
@ $43.2, valued at
$1.4M
Sold 11,318 shares
@ $45.32, valued at
$512.9k
Sold 12,829 shares
@ $46.47, valued at
$596.2k
Sold 30,347 shares
@ $42.03, valued at
$1.3M
|
|
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 10,952 shares
@ $35.49, valued at
$388.7k
Sold 10,258 shares
@ $36.03, valued at
$369.6k
Sold 16,856 shares
@ $34.46, valued at
$580.9k
Sold 500 shares
@ $35.37, valued at
$17.7k
|
|
| 11/24/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Disposed of 15,671 shares
@ $0
Sold 15,575 shares
@ $37.16, valued at
$578.8k
Sold 19,758 shares
@ $37.81, valued at
$747k
Sold 32,876 shares
@ $36.21, valued at
$1.2M
Sold 600 shares
@ $36.5, valued at
$21.9k
Sold 8,147 shares
@ $35.2, valued at
$286.8k
Sold 30,696 shares
@ $36.05, valued at
$1.1M
Sold 21,965 shares
@ $37.02, valued at
$813.1k
|
|
| 10/18/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 14,882 shares
@ $27.53, valued at
$409.7k
Sold 3,413 shares
@ $28.01, valued at
$95.6k
Sold 10,320 shares
@ $27.14, valued at
$280.1k
|
|
| 10/14/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 14,260 shares
@ $27.09, valued at
$386.3k
Sold 35,023 shares
@ $27.13, valued at
$950.2k
Sold 45,719 shares
@ $27.3, valued at
$1.2M
|
|
| 10/12/2021 |
4
| GADICKE ANSBERT (10% Owner) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Sold 1,922 shares
@ $27, valued at
$51.9k
Sold 3,400 shares
@ $27.01, valued at
$91.8k
Sold 81,684 shares
@ $27.24, valued at
$2.2M
|
|
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2021 |
4
| UBS Oncology Impact Fund L.P. (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 3,124 shares
@ $29.06, valued at
$90.8k
|
|
| 09/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2021 |
4
| UBS Oncology Impact Fund L.P. (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 7,106 shares
@ $29.17, valued at
$207.3k
Sold 6,425 shares
@ $29.16, valued at
$187.4k
|
|
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2021 |
4
| UBS Oncology Impact Fund L.P. (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 13,727 shares
@ $29.35, valued at
$402.9k
Sold 5,931 shares
@ $29.04, valued at
$172.2k
Sold 3,595 shares
@ $29.1, valued at
$104.6k
|
|
| 09/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2021 |
4
| UBS Oncology Impact Fund L.P. (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 12,731 shares
@ $29.6, valued at
$376.8k
Sold 25,067 shares
@ $29.04, valued at
$727.9k
Sold 10,842 shares
@ $29.11, valued at
$315.6k
|
|
| 09/02/2021 |
4
| UBS Oncology Impact Fund L.P. (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 1,285 shares
@ $29.43, valued at
$37.8k
Sold 1,553 shares
@ $30.14, valued at
$46.8k
Sold 5,714 shares
@ $29.47, valued at
$168.4k
Sold 15,757 shares
@ $29.46, valued at
$464.2k
|
|
| 08/31/2021 |
4
| UBS Oncology Impact Fund L.P. (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 13,357 shares
@ $29.09, valued at
$388.6k
Sold 31,001 shares
@ $29.3, valued at
$908.3k
|
|
| 08/25/2021 |
4
| UBS Oncology Impact Fund L.P. (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 53,359 shares
@ $29.11, valued at
$1.6M
Sold 50,822 shares
@ $29.48, valued at
$1.5M
Sold 1,713 shares
@ $29.09, valued at
$49.8k
|
|
| 08/12/2021 |
4
| UBS Oncology Impact Fund L.P. (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 2,510 shares
@ $29.05, valued at
$72.9k
|
|
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|